New biotech Slate Medicines raises $130M for migraine drug from Chinanews2026-02-24T12:30:21+00:00February 24th, 2026|Endpoints News|
Frontier, Harbour do licensing deals with GSK, Solsticenews2026-02-23T15:03:25+00:00February 23rd, 2026|Endpoints News|
Altesa raises $75M for oral respiratory mednews2026-02-19T12:00:31+00:00February 19th, 2026|Endpoints News|
Why clinical AI startup Kintsugi shut downnews2026-02-18T20:43:12+00:00February 18th, 2026|Endpoints News|
Paragon’s new biotech Korsana tackles Alzheimer’s like Rochenews2026-02-18T11:00:57+00:00February 18th, 2026|Endpoints News|
European VCs form coalition to get more support for biotech investingnews2026-02-12T10:00:29+00:00February 12th, 2026|Endpoints News|
Shanghai’s Cascade gets $72M to pursue MASH, obesity and diabetes drugsnews2026-02-10T15:50:13+00:00February 10th, 2026|Endpoints News|
Agomab, SpyGlass cap biggest week for biotech IPOs since 2021news2026-02-06T16:26:57+00:00February 6th, 2026|Endpoints News|
Veradermics CEO has a great hair day with 122% pop in IPOnews2026-02-05T18:34:42+00:00February 5th, 2026|Endpoints News|
Angitia gets $130M Series D for pipeline of musculoskeletal drugsnews2026-02-05T12:30:10+00:00February 5th, 2026|Endpoints News|
